On the other hand, TRAF3IP3 may facilitate glioma development by activating the ERK signaling pathway (Lin et al., 2022; Yang et al., 2021), while acting as a protective gene in patients with lung adenocarcinoma (Liu et al., 2021). The gene discussed is TRAF3IP3; the disease is glioma.